Winter Research Update
In the November 6th issue of Nature, Jae-won Shim, PhD, a NYSCF - Druckenmiller Fellow in Dr. Lorenz Studer's laboratory at Memorial Sloan-Kettering Cancer Center, detailed a potential new method for transforming stem cells into dopamine-producing neurons for Parkinson's treatment.
In the October 28th issue of Cell, Bi-Sen Ding, PhD, a NYSCF - Druckenmiller Fellow in Dr. Shahin Rafii's laboratory at Weill Cornell Medical College, presented the discovery of signals that "turn on" regeneration of oxygen-exchanging sacs in the lungs.
In the October issue of Cell Stem Cell, Marius Wernig, MD, PhD, a NYSCF - Robertson Investigator at Stanford University, reported on the successful transformation of mature liver cells from laboratory mice into functioning neurons.
In the November issue of Nature Methods, a team led by Paul Tesar, PhD, a NYSCF - Robertson Investigator at Case Western Reserve University, published a novel method in producing oligodendrocyte cells, the cells that are damaged in myelin-related disorders such as multiple sclerosis.
NYSCF - Robertson Investigator, Dr. Paul Tesar of Case Western Reserve University, published in Nature Methods today that they have succesfully produced the myelinating cells that die in multiple scerlosis and many other diseases. This is a step forward in finding treatments for many debilitating diseases.
Marco Seandel, MD, PhD, was named a NYSCF - Druckenmiller Fellow in 2008 and is in his third year of the NYSCF Fellowship Program. He was recently appointed to Assistant Professor of Cellular and Developmental Biology. On August, 6th, 2010, Marco's co-authored paper on stem cells of the testicles was published in Cell. Read an interview with Marco and learn about his research and how he became a scientist.
NYSCF Fellow Dr. Christopher Fasano recently published a paper in which he was able to create floor plate tissue from human embryonic stem cells (hESCs). This is the first study shown to derive floor plate tissue from hESCs. Read an interview with Chris here.